Variation in adult vaccination policies across Europe: An overview from VENICE network on vaccine recommendations, funding and coverage

Vaccine

Volumn 30, Issue 35, 2012, Pages 5222-5228

  Kanitz, Elisabeth E ^a,b   Wu, Lauren A ^c   Giambi, Cristina ^a   Strikas, Raymond A ^d   Levy Bruhl, Daniel ^e,h   Stefanoff, Pawel ^f,h   Mereckiene, Jolita ^g   Appelgren, Eva ^a   D'Ancona, Fortunato ^a,h   Klein, Jean Paul ^h   Sabbe, Martine ^h   Damme, Pierre Van ^h   Kojouharova, Mira ^h   Soteriou, Soteroulla ^h   Hadjianastassiou, Chrystalla ^h   Kriz, Bohumir ^h   Glismann, Steffen ^h   Kerbo, Natalia ^h   Filippova, Irina ^h   Leino, Tuija ^h   Reiter, Sabine ^h   Stavrou, Theodora ^h   Molnàr, Zsuzsanna ^h   Gudnason, Thorolfur ^h   Cotter, Suzanne ^h   Rota, Maria Cristina ^h   Perevoscikovs, Jurijs ^h   Valikoniene, Egle ^h   Berthet, Françoise ^h   Gauci, Charmaine ^h   Melillo, Tanya ^h   de Melker, Hester ^h   van Lier, Alies ^h   Feiring, Berit ^h   Fernandes, Teresa ^h   Valente, Paula ^h   Gratiana, Chicin ^h   Hudecova, Helena ^h   Lancova, Jarmila ^h   Kraigher, Alenka ^h   Calles, Josefa Masa ^h   Pachón del Amo, Isabel ^h   Linde, Annika ^h   Pebody, Richard ^h   more..

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^e INSTITUT DE VEILLE SANITAIRE   (France)

^f NATIONAL MEDICINES INSTITUTE   (Poland)

^g HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^h NONE

Author keywords

Adult Vaccination; Europe; Vaccination policy

Indexed keywords

BCG VACCINE; CHICKENPOX VACCINE; DIPHTHERIA TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE;

ARTICLE; BCG VACCINATION; EUROPEAN UNION; FUNDING; HEALTH CARE POLICY; HUMAN; MEASLES VACCINATION; PRIORITY JOURNAL; SEASONAL INFLUENZA; VACCINATION;

EID: 84863879480     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.012     Document Type: Article

References (28)

1. Challenges in global immunization and the Global Immunization Vision and Strategy 2006-2015; Wkly Epidemiol Rec. 2006 May 12;81(19):190-5.
2. Poland G.A., Jacobson R.M., Ovsyannikova I.G. Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine and consumer culture and vaccinomics. Vaccine 2009, 27:3240-3244.
3. Poland G.A., Belmin J., Langley J., Michel J.P., Van Damme P., Wicker S. A global prescription for adult immunization: time is catching up with us. Vaccine 2010, 28:7137-7139.
4. Lang P.O., Govind S., Michel J.P., Aspinall R., F Mitchell W.A. Immunosenescence implications for vaccination programmes in adults. Maturitas 2011, 68:322-330.
5. Michel J.P., Lang P.O. Promoting life course vaccination. Rejuvenation Res 2011 January 5, 10.1089/rej.2010.1078.
6. Siedler A., Mankertz A., Feil F., Ahlemeyer G., Hornig A., Kirchner M., et al. Closer to the goal: efforts in measles elimination in Germany 2010. J Infect Dis. 2011, 204(July (Suppl 1.)):S373-S380.
7. Wirsing von Koenig C.H., Campins-Marti M., Finn A., Guiso N., Mertsola J., Liese J. Pertussis immunization in the global pertussis initiative european region. Pediatr Infect Dis J 2005, 24:S87-S92.
8. Halperin S.A. Pertussis-a disease and vaccine for all ages. N Engl J Med. 2005, 353:1615-1617.
9. Zepp F., Heininger U., Mertsola J., Bernatowska E., Guiso N., Roord J., et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis. 2011, 11(July (7)):557-570.
10. Modelling hospital admissions for lower respiratory tract infections in the elderly in England. Epidemiol Infect. 2006 Dec;134(6):1150-7.
11. WHO Europe Eliminating measles and rubella. Framework for the verification progress in the WHO European Region. 2012. Available from: http://www.euro.who.int/__data/assets/pdf_file/0003/158304/EURO_MR_Elimi n_Verification_Processv2.pdf Last access: 17/05/2012.
12. WHO vaccine-preventable diseases: monitoring system 2010 global summary. WHO/IVB/2010. Available from: http://whqlibdoc.who.int/hq/2010/WHO_IVB_2010_eng.pdf Last access: 01/03/2012.
13. Mereckiene J., Cotter S., D'Ancona F., Giambi C., Nicoll A., Levy-Bruhl D., et al. VENICE project gatekeepers group. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill. 2010, 15(November (44)). pii: 19700.
14. Mereckiene J., Cotter S., Lopalco P., D'Ancona F., Levy-Bruhl D., Giambi C., et al. Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009?. Vaccine 2010, 28(June (28)):4470-4477.
15. Stefanoff P., Polkowska A., Giambi C., Levy-Bruhl D., O'Flanagan D., Dematte L., et al. VENICE project gatekeepers, contact persons group. Reliable surveillance of tick-borne encephalitis in European countries is necessary to improve the quality of vaccine recommendations. Vaccine 2011, 29(February (6)):1283-1288.
16. Dorleans F., Giambi C., Dematte L., Cotter S., Stefanoff P., Mereckiene J., et al. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE 2010 survey. Euro Surveill. 2010, 15(47). pii=19730.
17. Fitzgerald M., O'Donnell J., O'Flanagan D., Cafferkey M., Murphy K. Meningococcal disease in Ireland since the introduction of meningococcal serogroup C conjugate vaccination. Euro Surveill. 2004, 8(5). pii=2376.
18. Deneke M.G., Arguedas M.R. Hepatitis and considerations regarding the cost-effectiveness of vaccination programs. Expert Review of Vaccines 2003, 2(5):661-672.
19. Rupprecht C.E., Willoughby R., Slate D. Current and future trends in the prevention, treatment and control of rabies. Expert Rev Anti Infect Ther. 2006, 4(December (6)):1021-1038.
20. Vaudry W. To BCG or not to BCG, that is the question!. The challenge of BCG vaccination: why can't we get it right?. Paediatr Child Health. 2003, 8(March (3)):141-144.
21. WHO Europe WHO Epidmeiological Brief. N.19, November 2011. Available at: http://www.euro.who.int/__data/assets/pdf_file/0006/155940/Epi_Brief_Iss ue_19_Jan-Oct.pdf Last access: 17/05/2012.
22. Gautret P, Schlagenhauf P, Gaudart J, Castelli F, Brouqui P, von Sonnenburg F, et al. Multicenter EuroTravNet/GeoSentinel study of travel-related infectious diseases in Europe. Emerg Infect Dis [serial on the Internet]. 2009 Nov.
23. Haverkate M., D'Ancona F., Johansen K., van der Velden K., Giesecke J., Lopalco P.L. Assessing vaccination coverage in the European Union: is it still a challenge?. Expert Review of Vaccines 2011, 10(8):1195-1205.
24. Council recommendation of 22-12-2009 on seasonal influenza vaccination 2009/1019/EU. Official Journal of the European Union, 29/12/2009. Available at: http://www.epha.org/IMG/pdf/Council_Reccomendation_on_seasonal_flu_vacci ne.pdf Last access: 17/05/2012.
25. Pebody R. Vaccine registers-experiences from Europe and elsewhere. Euro Surveill. 2012, 17(17). pii=20159. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20159; 2012 [accessed 17.05.12].
26. VENICE II Consortium. Vaccination coverage assessment in EU/EEA, 2011. August 2011-March 2012. Available from:; 2011 [accessed 17.05.12]. http://venice.cineca.org/Final_Vaccination_Coverage_Assesment_Survey_201 1_1.pdf.
27. Napoli C., Tafuri S., Chironna M., Quarto M., Da Molin G. Cervical cancer prevention and health inequalities: an ad-hoc survey in Italian women. Public Health. 2011, (19).
28. Yi S., Nonaka D., Nomoto M., Kobayashi J., Mizoue T. Predictors of the uptake of A (H1N1) influenza vaccine: findings from a population-based longitudinal study in Tokyo. PLoS One 2011, 6(Apr (4)):e18893.